Morgan McLemore MD
Academic Appointment
- Co-course Director of the 2nd Year Medical Curriculum Hematology Module, Emory University School of Medicine
- Assistant Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine
Education
Degrees
- DO from University of Texas at San Antonio, San Antonio
- BS from Trinity University, San Antonio
Research
Focus
- My laboratory research focuses on understanding the signal transduction pathways that regulate Granulopoiesis. Our research has demonstrated that normal proliferative signals can contribute to DNA damage in marrow failure syndromes. Furthermore, we have found that Genistein a natural soy isofalvane is able to limit this DNA damage without compromising normal cellular production.
Publications
-
The Mortality of Adults With Sickle Cell Disease at a Comprehensive Sickle Cell Center.
Eur J Haematol Volume: 114 Page(s): 663 - 671
04/01/2025 Authors: Afranie-Sakyi JA; Randall E; Fasano R; McLemore ML; El Rassi F -
Concerns With Statistical Analysis of 2016 CDC Opioid Guideline and Sickle Cell Outcomes.
JAMA Intern Med Volume: 184 Page(s): 1133
09/01/2024 Authors: Patel AP; McLemore M; Sheehan VA -
Characteristics of Emergency Department Visits Made by Individuals With Sickle Cell Disease in the U.S., 1999-2020.
AJPM Focus Volume: 3 Page(s): 100158
02/01/2024 Authors: Attell BK; Barrett PM; Pace BS; McLemore ML; McGee BT; Oshe R; DiGirolamo AM; Cohen LL; Snyder AB -
Adult-onset Langerhans cell histiocytosis of bone: A case series highlighting a rare entity.
Ann Diagn Pathol Volume: 66 Page(s): 152171
10/01/2023 Authors: Javadi T; Hill C; McLemore ML; Oskouei S; Bahrami A -
Enhanced IgG immune response to COVID-19 vaccination in patients with sickle cell disease.
Br J Haematol Volume: 202 Page(s): 937 - 941
09/01/2023 Authors: Nakahara H; Cheedarla N; Verkerke HP; Cheedarla S; Wu S-C; Hendrickson JE; Chang A; McLemore ML; El Rassi F; Roback JD -
Evaluating the Discriminatory Ability of the Sickle Cell Data Collection Program's Administrative Claims Case Definition in Identifying Adults With Sickle Cell Disease: Validation Study.
JMIR Public Health Surveill Volume: 9 Page(s): e42816
06/28/2023 Authors: Singh A; Sontag MK; Zhou M; Dasgupta M; Crume T; McLemore M; Galadanci N; Randall E; Steiner N; Brandow AM -
Presentations and outcomes among sickle cell disease patients with COVID-19 at a large southern healthcare system.
Expert Rev Hematol Volume: 16 Page(s): 151 - 156
02/01/2023 Authors: Clarke K; Shin YM; Hall MAK; Moussa M; McLemore M; El Rassi F -
Catastrophic Neurological Complications in 2 Patients With Sickle Cell Disease and COVID-19.
J Investig Med High Impact Case Rep Volume: 10 Page(s): 23247096221111778
01/01/2022 Authors: Clarke K; Benameur K; Wiley Z; Shin YM; Moussa M; El Rassi F; McLemore M -
Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia.
JCO Oncol Pract Volume: 17 Page(s): e497 - e505
04/01/2021 Authors: Jillella AP; Arellano ML; Gaddh M; Langston AA; Heffner LT; Winton EF; McLemore ML; Zhang C; Caprara CR; Simon KS -
Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR).
Blood Cells Mol Dis Volume: 87 Page(s): 102534
03/01/2021 Authors: Niss O; Lorsbach RB; Berger M; Chonat S; McLemore M; Buchbinder D; McCavit T; Shaffer LG; Simpson J; Schwartz JH